PURPOSE
The development of drug-resistant phenotypes has been a major obstacle to cisplatin use in non-small-cell lung cancer. We aimed to identify some of the molecular mechanisms that underlie cisplatin resistance using microarray expression analysis.
METHODS AND MATERIALS
H460 cells were treated with cisplatin. The differences between cisplatin-resistant lung cancer cells and parental H460...
